1.
2.
Toxic epidermal necrolysis possibly associated with mogamulizumab in a patient with Sézary syndrome.
J Eur Acad Dermatol Venereol
; 37(6): e715-e717, 2023 06.
Article
in English
| MEDLINE
| ID: mdl-36645855